With a first degree in Biochemistry and Pharmacology and a PhD focusing on drug metabolism and Pharmacokinetics, Dr. Graeme Ladds has worked in the areas of Drug Safety and Medical services for over 30 years.
Graeme has been working as Head of Global Pharmacovigilance for a multi-national innovator Company, and EU QP PV for many of the top ten Pharma Companies, and small Pharma and has been CEO for the last 19 years for PharSafer®.
Graeme is also a member of the DIA; TOPRA; RQA, PIPA and MAPS and has helped small start-up Companies (Biotech; Medical Devices; Biologics; Generics; Herbal; OTC) in their planning, growth and has been involved in Company and product acquisitions, due diligence activities for product in-licensing and marketing and development strategies with partner and distributor Companies.
Graeme has been involved in many drug-development programs, taking products from the bench to market in a wide range of therapeutic areas, and also has an additional role as Research & Development Director for products to be developed for global launches.
Graeme’s 31-year journey in drug safety, where there was little structure to be trained in pharmacovigilance or availability for finding out the global regulations, fueled his desire to ensure there would be an extensive training program for all the PharSafer® people to promote and simplify their drug safety careers.
This has resulted in many staff now having remained with the Company for over ten years, providing Company stability and in-depth expertise. Additionally, to aid all drug safety professionals in their careers, SaPhar Training® - sister Company to PharSafer® - has performed training all over the world, with varied bespoke and formatted training courses for all levels of experience since 2003.
